B-CELL LYMPHOMA
Clinical trials for B-CELL LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug targets Hard-to-Treat blood cancers in early trial
Disease control Not yet recruitingThis early-stage study tests a new drug called LY4152199 in about 215 adults with B-cell cancers like lymphoma that have come back or not responded to prior treatment. The drug is designed to help the body's immune cells attack cancer cells. The main goals are to find the safest …
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated May 17, 2026 03:09 UTC
-
Engineered immune cells take on tough blood cancers
Disease control Not yet recruitingThis study tests a new treatment using a patient's own immune cells, modified to target and kill cancer cells in adults with leukemia or lymphoma that has come back or not responded to standard therapy. The trial has two phases: first to check safety, then to see how well the tre…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology • Aim: Disease control
Last updated May 15, 2026 12:07 UTC
-
New hope for hard-to-treat blood cancers: phase 3 trial compares two targeted drugs
Disease control Not yet recruitingThis study tests a new drug, NX-5948, against another drug, pirtobrutinib, in people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) whose cancer has returned or stopped responding to a prior targeted therapy. About 620 adults will be randomly assigned…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE3 • Sponsor: Nurix Therapeutics, Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Can a daily pill keep lymphoma away after CAR-T?
Disease control Not yet recruitingThis study looks at whether taking zanubrutinib (a pill) after CAR-T cell therapy can help keep non-Hodgkin B-cell lymphoma under control for longer. About 40 adults who have already had or are about to have CAR-T therapy will take zanubrutinib and be followed for 2 years. The go…
Matched conditions: B-CELL LYMPHOMA
Sponsor: Beijing GoBroad Hospital • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Double-Pronged CAR t cells take on tough blood cancers
Disease control Not yet recruitingThis early-phase trial tests a new type of CAR T cell therapy that targets two proteins (CD19 and CD20) on cancer cells. It is for adults with B-cell leukemia or lymphoma who have run out of standard treatments, including commercial CAR T cells. The main goal is to check safety a…
Matched conditions: B-CELL LYMPHOMA
Phase: PHASE1 • Sponsor: University Hospital, Basel, Switzerland • Aim: Disease control
Last updated May 01, 2026 15:57 UTC